Monitoring Specific T-Cell Responses to Melanoma Vaccines: ELISPOT, Tetramers, and Beyond

This publication has 19 references indexed in Scilit:

• Evaluation of the Modified ELISPOT Assay for Gamma Interferon Production in Cancer Patients Receiving Antitumor Vaccines
  Clinical and Diagnostic Laboratory Immunology, 2000
• High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals
  The Journal of Experimental Medicine, 1999
• Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
  Nature Medicine, 1999
• MHC-based diagnostics and therapeutics – clinical applications for disease-linked genes
  Immunology Today, 1999
• Phenotypic Analysis of Antigen-Specific T Lymphocytes
  Science, 1996
• Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.
  The Journal of Experimental Medicine, 1996
• THE IMMUNOTHERAPY OF SOLID CANCERS BASED ON CLONING THE GENES ENCODING TUMOR-REJECTION ANTIGENS
  Annual Review of Medicine, 1996
• Alterations in Signal Transduction in T Cells from Cancer Patients
  Published by Springer Nature ,1995
• Tumor Antigens Recognized by T Lymphocytes
  Annual Review of Immunology, 1994
• Precursor frequency analysis of human cytolytic T lymphocytes directed against autologous melanoma cells
  International Journal of Cancer, 1992